Most large cryptocurrencies were up during U.S. morning trading on Wednesday, with XRP XRPUSD seeing the biggest change, climbing 1.81% to $1.36. Six additional currencies posted raises Wednesday.

Shares of space companies ticked up after SpaceX reported surging revenue in the latest quarter and signaled more robust growth in the months ahead, in a sign of strong demand for commercial space ...

Iren plans to offer AI cloud services from the data center, including managed services, with the aim of meeting customer demand for greater choice over where their AI workloads ru ...

Voyager Therapeutics has appointed Robin Swartz as its new chief executive officer. Swartz has also been named president, effective immediately, and will transition to the CEO role in the first ...

The person shouted something that could not be heard on the company’s livestream about 20 minutes into the address, before ...

NextEra Energy's third-quarter net income rose sharply and the electricity giant guided towards the high end of its 2026 adjusted earnings growth target, anticipating a long-term boom in ...

AdL issued a non-binding all-cash proposal valuing the company at 46 pence a share, Mobico said--around a 55% premium to its closing share price Tuesday. The offer values the comp ...

Huntington Ingalls' board has raised the defense company's quarterly dividend by 2.2%, to $1.41 from $1.38. The new payout, equal to $5.64 a year, represents an annual yield of about 2.07% based on ...

Prosperity Bancshares' board has raised the financial holding company's quarterly dividend by 6.7%, to 64 cents from 60 cents. The new payout, equal to $2.56 a year, represents an annual yield of ...

Government data released this week shows an uptick in both savings and CD APYs. We look into where to find solid rates, and ...

The RV maker targeted earnings for the fiscal year 2027 in a range between 90 cents and $1.50 a share. Winnebago projected adjusted earnings for the year of $1.65 to $2.25 a share, short of the ...

Shares of Roivant rose on positive results from phase 3 trials evaluating a treatment for non-infectious uveitis (NIU), a condition that's a leading cause of blindness. The stock gained 8.1% to $37.74 ...